TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Benchmark Genetics Salten AS
Closing information (x1000 EUR)
Closing information | 2023/09 | 2022/09 | 2021/09 |
Turnover |
25,980
|
19,753
|
16,830 |
Financial expenses |
1,635
|
1,222
|
1,232 |
Earnings before taxes |
5,588
|
6,383
|
1,952 |
Total assets |
64,017
|
57,974
|
53,130 |
Current assets |
25,141
|
16,674
|
10,360 |
Current liabilities |
14,426
|
10,823
|
7,935 |
Equity capital |
23,811
|
20,818
|
15,783 |
- share capital |
2,222
|
2,391
|
2,456 |
Financial ratios
Fiscal year | 2023/09 | 2022/09 | 2021/09 |
Solvency |
37.2%
|
35.9%
|
29.7% |
Turnover per employee | |||
Profit as a percentage of turnover |
21.5%
|
32.3%
|
11.6% |
Return on assets (ROA) |
11.3%
|
13.1%
|
6.0% |
Current ratio |
174.3%
|
154.1%
|
130.6% |
Return on equity (ROE) |
23.5%
|
30.7%
|
12.4% |
Change turnover |
7,626
|
3,365
|
6,514 |
Change turnover % |
42%
|
21%
|
63% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2023/09 | 2022/09 | 2021/09 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.